Anderlik P, Szeri I, Bános Z
Ann Immunol Hung. 1975;18:53-6.
F1 hybrid mice (C57BL X C3H) suffering from graft-versus-host disease, were treated with dianhydrodulcit (DAD) a lymphotrop cytostatic agent. 15 mg/kg of the compound was injected intraperitoneally, 8 days following the administration of the parental spleen cell suspension. The interaction between the two interventions is discussed on the basis of the rate and time course of deaths observed is the individual groups, as well as on the state of the lymphoid organs of the succumbed and sacrificed animals.
患有移植物抗宿主病的F1杂种小鼠(C57BL×C3H),用亲淋巴细胞性细胞生长抑制剂二脱水卫矛醇(DAD)进行治疗。在给予亲代脾细胞悬液8天后,以15mg/kg的剂量腹腔注射该化合物。根据各个组观察到的死亡速率和时间进程,以及死亡和处死动物的淋巴器官状态,对两种干预措施之间的相互作用进行了讨论。